Vivo Capital, LLC Q1 2019 Filing
Filed May 14, 2019
Portfolio Value
$1.0T
Holdings
49
Report Date
Q1 2019
Filing Type
13F-HR
All Holdings (49 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDAscendis Pharma A/S | 2,046,832 | $240.9B | 24.02% | |
| 2 | CRNXCrinetics Pharmaceuticals Inc | 3,375,169 | $76.8B | 7.66% | |
| 3 | CDXSCodexis, Inc | 2,618,951 | $53.8B | 5.36% | |
| 4 | ARWRArrowhead Pharmaceuticals Inc | 2,328,475 | $42.7B | 4.26% | |
| 5 | KALVKalVista Pharmaceuticals Inc. | 1,359,149 | $38.9B | 3.88% | |
| 6 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 3.81% | |
| 7 | IM8NInsmed Inc | 1,170,290 | $34.0B | 3.39% | |
| 8 | —Kadmon Holdings Inc | 12,606,605 | $33.3B | 3.32% | |
| 9 | FIXXEURHomology Medicines, Inc. | 1,159,742 | $32.2B | 3.21% | |
| 10 | —Menlo Therapeutics Inc. | 4,011,236 | $31.5B | 3.14% | |
| 11 | 1T7Tricida, Inc. | 781,185 | $29.5B | 2.94% | |
| 12 | CBAYUSDCymabay Therapeutics Inc | 2,056,000 | $27.3B | 2.72% | |
| 13 | —Biohaven Pharmaceutical Holding Company Ltd | 504,980 | $26.0B | 2.59% | |
| 14 | CLDNEUREiger BioPharmaceuticals Inc | 1,791,257 | $25.0B | 2.50% | |
| 15 | MRTXEURMirati Therapeutics Inc. | 251,107 | $18.4B | 1.84% | |
| 16 | MEIPUSDMEI Pharma Inc | 5,778,106 | $17.7B | 1.77% | |
| 17 | KNSAKiniksa Pharmaceuticals | 843,478 | $15.2B | 1.52% | |
| 18 | IOVAIovance Biotherapeutics, Inc. | 1,600,000 | $15.2B | 1.52% | |
| 19 | XENEXenon Pharmaceuticals Inc | 1,405,476 | $14.3B | 1.42% | |
| 20 | —Acer Therapeutics Inc | 579,051 | $14.1B | 1.40% | |
| 21 | —Obseva SA | 937,147 | $12.0B | 1.20% | |
| 22 | AMRSEURAmyris, Inc | 5,575,785 | $11.7B | 1.16% | |
| 23 | QUREUniqure NV | 180,336 | $10.8B | 1.07% | |
| 24 | —Nabriva Therapeutics AG | 4,403,687 | $10.7B | 1.07% | |
| 25 | —Zymeworks Inc | 620,134 | $10.0B | 1.00% | |
| 26 | ACRSAclaris Therapeutics, Inc. | 1,647,214 | $9.9B | 0.98% | |
| 27 | VRNAVerona Pharma PLC | 1,492,951 | $9.7B | 0.97% | |
| 28 | —Dermira Inc | 700,000 | $9.5B | 0.95% | |
| 29 | —Soleno Therapeutics, Inc. | 4,359,683 | $9.0B | 0.90% | |
| 30 | KALAKala Pharmaceuticals, Inc. | 1,043,020 | $8.6B | 0.86% | |
| 31 | ORTXUSDOrchard Therapeutics plc | 481,609 | $8.6B | 0.86% | |
| 32 | GLMDGalmed Pharmaceuticals Ltd | 971,337 | $7.9B | 0.79% | |
| 33 | AUPHAurinia Pharmaceuticals Inc. | 1,213,290 | $7.9B | 0.79% | |
| 34 | APLSApellis Pharmaceuticals, Inc. | 383,538 | $7.5B | 0.75% | |
| 35 | MTNBEURMatinas Biopharma Hldgs Inc | 6,818,181 | $7.4B | 0.74% | |
| 36 | —Zogenix Inc | 105,000 | $5.8B | 0.58% | |
| 37 | DTILPrecision Biosciences Inc | 280,511 | $5.0B | 0.50% | |
| 38 | —Genocea Biosciences Inc | 7,811,206 | $4.6B | 0.46% | |
| 39 | —Strongbridge Biopharma plc | 914,062 | $4.6B | 0.45% | |
| 40 | —Sierra Oncology, Inc | 2,438,270 | $4.2B | 0.42% | |
| 41 | —Agile Therapeutics, Inc. | 1,513,975 | $2.3B | 0.23% | |
| 42 | ZLABZai Lab Limited | 71,595 | $2.1B | 0.21% | |
| 43 | —DBV Technologies S.A. | 269,995 | $2.1B | 0.21% | |
| 44 | —Trevena, Inc. | 1,233,677 | $1.9B | 0.19% | |
| 45 | —BioPharmX Corporation | 16,128,515 | $1.4B | 0.14% | |
| 46 | SELBUSDSelecta Biosciences Inc | 546,054 | $1.3B | 0.13% | |
| 47 | —Akari Therapeutics Plc | 345,850 | $1.2B | 0.12% | |
| 48 | —Sunesis Pharmaceuticals, Inc. | 99,441 | $121.0M | 0.01% | |
| 49 | —Soleno Therapeutics, Inc. - Warrant | 188,772 | $28.0M | 0.00% |